← Back to Search

Other

1 for Diabetes

Phase 1
Waitlist Available
Research Sponsored by GAAD Medical Research Institute Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Persons with type 1 or type 2 diabetes
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Study Summary

A study to determine the use of far infrared (FIR) radiation for treatment of diabetes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The primary end point is to determine the therapeutic effects of far infrared radiation on all types of diabetes.
Secondary outcome measures
Adrenal gland hypofunction

Trial Design

1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

GAAD Medical Research Institute Inc.Lead Sponsor
21 Previous Clinical Trials
93 Total Patients Enrolled
Ken Nedd, M.D.Study DirectorGAAD Medical Research Institute Inc.
19 Previous Clinical Trials
91 Total Patients Enrolled
Kwasi Donyina, Ph.D.Study ChairGAAD Medical Research Institute Inc.
13 Previous Clinical Trials
52 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~0 spots leftby Apr 2025